Browsing: Johnson

He claims to have spent millions of dollars tracking and streamlining nearly every aspect of his biology so as to radically slow — and even reverse, he claims — aging. He’s undeniably fit, purports to get more than eight hours of sleep each night and boasts a “fertility age” in his early twenties. Johnson is…

Eli Lilly (NYSE: LLY) is a Wall Street darling thanks to its success in the GLP-1 weight-loss market. There’s a problem here, however, because weight-loss drugs now account for nearly two-thirds of the drug maker’s revenues. Johnson & Johnson (NYSE: JNJ) CEO Joaquin Duato isn’t interested in being so reliant on just one healthcare niche.…